Journal of Gastrointestinal Oncology
短名 | J Gastrointest Oncol |
Journal Impact | 2.04 |
国际分区 | ONCOLOGY(Q3) |
期刊索引 | SCI Q4中科院 4 区 |
ISSN | 2078-6891, 2219-679X |
h-index | 55 |
国内分区 | 医学(4区)医学胃肠肝病学(4区)医学肿瘤学(4区) |
OURNAL OF GASTROINTESTINAL ONCOLOGY (PRINT ISSN 2078-6891; ONLINE ISSN 2219-679X; J GASTROINTEST ONCOL; JGO) 是胃肠肿瘤学会 (SGO) 的官方期刊,是一本开放获取的国际同行评审期刊。它每季度出版一次(2010 年 9 月至 2013 年 12 月)、双月刊(2014 年 2 月至今),并在全球范围内公开发行。JGO 出版的手稿侧重于有关胃肠道癌症治疗的诊断、预防和临床研究的最新实用信息。感兴趣的具体领域包括但不限于多模式治疗、标志物、成像和肿瘤生物学。
投稿网址涉及主题 | 医学内科学生物遗传学癌症外科病理肿瘤科化学生物化学结直肠癌放射科胃肠病学数学化疗统计癌症研究免疫学 |
出版信息 | 出版商: AME Publishing Company,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2012,原创研究文献占比: 91.85%,自引率:5.00%, Gold OA占比: 97.93% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Risk factors contributing to morbidity associated with feeding tubes placed for esophageal cancer patients undergoing esophagectomy: a single-center retrospective study
2024-8-1
Corticosteroid-dependent immune checkpoint inhibitor-induced enterocolitis treated with vedolizumab: a case report
2024-8-1
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation
2024-8-1
Exploring the complexities of metachronous primary tumors after surgically managed pancreatic cancer—why lightning strikes twice
2024-8-1
A novel model based on protein post-translational modifications comprising the immune landscape and prediction of colorectal cancer prognosis
2024-8-1
YAP-based nomogram predicts poor prognosis in patients with hepatocellular carcinoma after curative surgery
2024-8-1
PD-1 blockade combined with chemotherapy and bevacizumab in DNA mismatch repair-proficient/microsatellite stable colorectal liver metastases
2024-8-1
PLK1 and its role in the evolving landscape of KRAS-mutated colorectal cancer
2024-8-1
Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer
2024-8-1
Stereotactic body radiation therapy in non-liver colorectal metastases: a scoping review
2024-8-1
Duodenal neuroendocrine tumors: how safe is endoscopic resection?
2024-8-1
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?
2024-8-1
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomized controlled trial
2024-8-1
Response to hepatic arterial infusion chemotherapy combined with camrelizumab and targeted therapy in advanced primary hepatic neuroendocrine carcinoma: a case report and literature review
2024-8-1
Discontinuation of immune checkpoint inhibitors in hepatocellular carcinoma: a retrospective cohort study
2024-8-1
Transverse colon cancer: a call for focused research in an understudied heterogenous disease
2024-8-1
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients
2024-8-1
Epidemiology, survival and new treatment modalities for intrahepatic cholangiocarcinoma
2024-8-1
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study
2024-8-1
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma
2024-8-1
PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a potential biomarker for immunotherapy
2024-8-1
Particle therapy in gastrointestinal cancer—a narrative review
2024-8-1
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor
2024-8-1
Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature
2024-8-1
Modern times call for modernized treatment strategies for advanced gastrointestinal stromal tumors
2024-8-1
Integrated molecular profiling of RAS, BRAF mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality
2024-8-1
Single-cell analysis of chemotherapy-resistant microenvironment identifies a chemo-response biomarker for pancreatic cancer
2024-8-1
DNA signature and occult blood in stool led to diagnosis of an early-onset metastatic rectal cancer in a young pregnant woman: a case report
2024-8-1
MRTX1133’s promise for treating KRASG12D-mutant pancreatic cancer
2024-8-1
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway
2024-8-1
The emerging role of FAM46C as a biomarker and therapeutic target in gastric adenocarcinoma
2024-8-1
Laparoscopic two-step abdomino-parasacral resection of a giant pelvic lipoma: a case report
2024-8-1
Concomitant or antecedent intraductal papillary mucinous neoplasm is not a prognostic factor in resected pancreatic cancer
2024-8-1
Clinical features and risk of multiple primary malignancies after endoscopic treatment in patients with early esophageal squamous cell carcinoma: a retrospective cohort study
2024-8-1
The benefit of adjuvant chemotherapy in pathological T1–3N0M0 rectal mucinous adenocarcinoma: no improvement survival outcomes based on long-term survival analysis of large population data
2024-8-1
Gut microbiota modulation: the key to improving outcomes after colorectal cancer surgery?
2024-8-1
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER database
2024-8-1
Efficacy and safety of camrelizumab combined with chemotherapy in the first-line treatment of advanced gastric cancer: a single-arm, phase II study
2024-8-1
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer
2024-8-1
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study
2024-8-1
Laparoscopic distal pancreatectomy for pancreatic cancer: an overview of evaluation and treatment strategies
2024-8-1
The impact of transanal drainage tube on the incidence of anastomotic leakage and small bowel obstruction in radical surgery (Dixon) for rectal cancer: a retrospective cohort study
2024-8-1
Tumor complete response and pyogenic liver abscess secondary to concurrent microwave ablation plus atezolizumab and bevacizumab in liver cancer: a case report
2024-8-1
Proteome-wide Mendelian randomization and single-cell sequencing analysis identify the association between plasma proteins and gastric cancer
2024-8-1
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology
2024-8-1
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer
2024-8-1
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study
2024-8-1
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review
2024-8-1
Stereotactic body radiation therapy for colorectal cancer liver metastases
2024-8-1
Association between sleep traits and risk of colorectal cancer: a bidirectional Mendelian randomization study
2024-8-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远